List of Seattle Children's patents

Patents where

Current Assignee

Name

Seattle Children's

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11408005 Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells		Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11408005	August 9, 2022
‌ US Patent 11414486 Transgene genetic tags and methods of use	Patent 11414486 was granted and assigned to Seattle Children's on August, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11414486	August 16, 2022
‌ US Patent 8381723 Broad-band, low frequency, high-amplitude, long time duration, oscillating airway pressure breathing apparatus and method utilizing bubbles	Patent 8381723 was granted and assigned to Seattle Children's on February, 2013 by the United States Patent and Trademark Office.		Seattle Children's	United States Patent and Trademark Office	8381723	February 26, 2013
‌ US Patent 11518814 Early intervention methods to prevent or ameliorate toxicity	Patent 11518814 was granted and assigned to Seattle Children's on December, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11518814	December 6, 2022
‌ US Patent 10266592 Drug regulated transgene expression	Patent 10266592 was granted and assigned to Seattle Children's on April, 2019 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10266592	April 23, 2019
‌ US Patent 11458167 Bispecific CAR T-cells for solid tumor targeting	Patent 11458167 was granted and assigned to Seattle Children's on October, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11458167	October 4, 2022
‌ US Patent 10525082 Genetic engineering of macrophages for immunotherapy	Patent 10525082 was granted and assigned to Seattle Children's on January, 2020 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10525082	January 7, 2020
‌ US Patent 9447194 Bispecific chimeric antigen receptors and encoding polynucleotides thereof	Patent 9447194 was granted and assigned to Seattle Children's on September, 2016 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	9447194	September 20, 2016
‌ US Patent 11639387 Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of use thereof to treat disease	Patent 11639387 was granted and assigned to Seattle Children's on May, 2023 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11639387	May 2, 2023
‌ US Patent 10189903 Bispecific chimeric antigen receptors and methods of use thereof to treat cancer	Patent 10189903 was granted and assigned to Seattle Children's on January, 2019 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10189903	January 29, 2019
‌ US Patent 11529404 Doubly attenuated late liver stage malaria parasites and related compositions and methods	Patent 11529404 was granted and assigned to Seattle Children's on December, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11529404	December 20, 2022
‌ US Patent 9943612 Long poly(A) plasmids and methods for introduction of long poly(A) sequences into the plasmid	Patent 9943612 was granted and assigned to Seattle Children's on April, 2018 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	9943612	April 17, 2018
‌ US Patent 11253569 Methods of treating Kawasaki Disease	Patent 11253569 was granted and assigned to Seattle Children's on February, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11253569	February 22, 2022
‌ US Patent 11649288 Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents	Patent 11649288 was granted and assigned to Seattle Children's on May, 2023 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11649288	May 16, 2023
‌ US Patent 11643671 Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked thrombocytopenia	Patent 11643671 was granted and assigned to Seattle Children's on May, 2023 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11643671	May 9, 2023
‌ US Patent 11400169 Long poly(A) plasmids and methods for introduction of long poly(A) sequences into the plasmid	Patent 11400169 was granted and assigned to Seattle Children's on August, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11400169	August 2, 2022
‌ US Patent 11311576 Methods of use for CAR T cells	Patent 11311576 was granted and assigned to Seattle Children's on April, 2022 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	11311576	April 26, 2022
‌ US Patent 9168296 Detection and treatment of autoimmune disorders	Patent 9168296 was granted and assigned to Seattle Children's on October, 2015 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	9168296	October 27, 2015
‌ US Patent 10829556 Polynucleotides encoding bispecific chimeric antigen receptors	Patent 10829556 was granted and assigned to Seattle Children's on November, 2020 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10829556	November 10, 2020
‌ US Patent 10563226 Enhancing endonuclease based gene editing in primary cells	Patent 10563226 was granted and assigned to Seattle Children's on February, 2020 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10563226	February 18, 2020
‌ US Patent 10919950 Tumor-specific IFNA secretion by car T-cells to reprogram the solid tumor microenvironment	Patent 10919950 was granted and assigned to Seattle Children's on February, 2021 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10919950	February 16, 2021
‌ US Patent 10611837 Transgene genetic tags and methods of use	Patent 10611837 was granted and assigned to Seattle Children's on April, 2020 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10611837	April 7, 2020
‌ US Patent 9576503 Simulation cart	Patent 9576503 was granted and assigned to Seattle Children's on February, 2017 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	9576503	February 21, 2017
‌ US Patent 10865242 Method and compositions for cellular immunotherapy	Patent 10865242 was granted and assigned to Seattle Children's on December, 2020 by the United States Patent and Trademark Office.	Seattle Children's	Seattle Children's	United States Patent and Trademark Office	10865242	December 15, 2020
‌ US Patent 9486353 Spring-biased nasal molding device	Patent 9486353 was granted and assigned to Seattle Children's on November, 2016 by the United States Patent and Trademark Office.		Seattle Children's	United States Patent and Trademark Office	9486353	November 8, 2016

Results per page:

48 results

0 selected

48 results

0 selected